Overview

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects

Status:
Completed

Trial end date:
2012-09-01

Target enrollment:

Participant gender:

Summary

This study is to characterize the Pharmacokinetics (PK) of unconjugated and total Rotigotine after single and multiple doses of Rotigotine transdermal patch, and also to investigate the safety and tolerability of Rotigotine transdermal patch in healthy Chinese subjects.

Phase:

Phase 1

Details

Lead Sponsor:

UCB Pharma

Treatments:

N 0437
Rotigotine